PLGO Stock Analysis: PLGO | NYSE
Insurance - Diversified | NYSE, USA | Market Cap: 1.947m USD | 12M Return: 41.8% | BMG3398L1182 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 10.1M
Qual. Beats: -1
Rev. Trend: -59.4%
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 3.2 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Pelagos Insurance Capital Limited (NYSE: PLGO) is a Bermuda-domiciled insurance and reinsurance provider operating across Bermuda, Ireland, and the United Kingdom. The company runs two segments: Insurance, covering specialty lines such as property, marine, aviation and aerospace, political risk, energy, and cyber, and Reinsurance, which offers property, retrocession, and whole account solutions. Incorporated in 2014 and headquartered in Pembroke, Bermuda, the company was formerly known as Fidelis Insurance Holdings Limited before adopting its current name in May 2026. Bermuda is a leading global hub for specialty insurance and reinsurance, known for its favorable regulatory environment and concentration of risk-bearing entities.
- Cat losses erode property underwriting margin and combined ratio
- Specialty rate softening pressures premium growth across Insurance segment
- Reinsurance pricing hardens supporting margin expansion in retrocession
| Net Income: 400.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 8.55 > 1.0 |
| NWC/Revenue: -185.5% < 20% (prev 64.16%; Δ -249.7% < -1%) |
| CFO/TA 0.06 > 3% & CFO 631.5m > Net Income 400.7m |
| Net Debt (231.9m) to EBITDA (445.5m): 0.52 < 3 |
| Current Ratio: 0.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (85.1m) vs 12m ago -22.02% < -2% |
| Gross Margin: 51.16% > 18% (prev 14.63%; Δ 36.53% > 0.5%) |
| Asset Turnover: 18.20% > 50% (prev 19.47%; Δ -1.27% > 0%) |
| Interest Coverage Ratio: 8.06 > 6 (EBIT TTM 459.7m / Interest Expense TTM 57.0m) |
| A: -0.37 (Total Current Assets 5.10b - Total Current Liabilities 9.11b) / Total Assets 10.8b |
| B: 0.07 (Retained Earnings 802.5m / Total Assets 10.8b) |
| C: 0.04 (EBIT TTM 459.7m / Avg Total Assets 11.9b) |
| D: 0.26 (Book Value of Equity 2.22b / Total Liabilities 8.54b) |
| Altman-Z'' = -1.67 = D |
As of September 27, 2026, the stock is trading at USD 23.96 with a total of 412,300 shares traded. Over the past week, the price has changed by +1.78%, over one month by -0.23%, over three months by +1.40% and over the past year by +41.76%.
Current recommended Stop Loss: 22.60 (which is 5.7% or 2.5 ATR below the current price).
PLGO has no consensus analysts rating.
P/E Trailing = 5.8412
P/E Forward = 5.2576
P/S = 0.7748
P/B = 0.877
Revenue TTM = 2.16b USD
EBIT TTM = 459.7m USD
EBITDA TTM = 445.5m USD
Long Term Debt = 720.5m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 749.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 28.5m
Net Debt = 231.9m USD (calculated: Debt 749.0m - CCE 517.1m)
Enterprise Value = 2.18b USD (1.95b + Debt 749.0m - CCE 517.1m)
Interest Coverage Ratio = 8.06 (Ebit TTM 459.7m / Interest Expense TTM 57.0m)
EV/FCF = 3.46x (Enterprise Value 2.18b / FCF TTM 630.1m)
FCF Yield = 28.91% (FCF TTM 630.1m / Enterprise Value 2.18b)
FCF Margin = 29.15% (FCF TTM 630.1m / Revenue TTM 2.16b)
Net Margin = 18.54% (Net Income TTM 400.7m / Revenue TTM 2.16b)
Gross Margin = 51.16% ((Revenue TTM 2.16b - Cost of Revenue TTM 1.06b) / Revenue TTM)
Gross Margin QoQ = 53.14% (prev 63.45%)
Tobins Q-Ratio = 0.20 (Enterprise Value 2.18b / Total Assets 10.8b)
Interest Expense / Debt = 7.61% (Interest Expense 57.0m / Debt 749.0m)
Taxrate = 12.83% (59.0m / 459.7m)
NOPAT = 400.7m (EBIT 459.7m * (1 - 12.83%))
Current Ratio = 0.56 (Total Current Assets 5.10b / Total Current Liabilities 9.11b)
Debt / Equity = 0.34 (Debt 749.0m / totalStockholderEquity, last quarter 2.22b)
Debt / EBITDA = 0.52 (Net Debt 231.9m / EBITDA 445.5m)
Debt / FCF = 0.37 (Net Debt 231.9m / FCF TTM 630.1m)
Total Stockholder Equity = 2.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.37% (Net Income 400.7m / Total Assets 10.8b)
RoE = 17.25% (Net Income TTM 400.7m / Total Stockholder Equity 2.32b)
RoCE = 15.11% (EBIT 459.7m / Capital Employed (Equity 2.32b + L.T.Debt 720.5m))
RoIC = 26.04% (NOPAT 400.7m / Invested Capital 1.54b)
WACC = 6.78% (E(1.95b)/V(2.70b) * Re(6.84%) + D(749.0m)/V(2.70b) * Rd(7.61%) * (1-Tc(0.13)))
Discount Rate = 6.84% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.99 | Cagr: -13.63%
[DCF] Terminal Value 75.44% ; FCFF base≈630.1m ; Y1≈632.7m ; Y5≈670.2m
[DCF] Fair Price = 123.2 (EV 10.4b - Net Debt 231.9m = Equity 10.2b / Shares 82.7m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -2.81 | # QB: -1
Revenue Correlation: -59.40 | Revenue CAGR: -11.34% | SUE: N/A | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.67 | Chg30d=-5.32% | Revisions=-22% | Analysts=9
EPS current Year (2026-12-31): EPS=2.98 | Chg30d=-15.88% | Revisions=-75% | GrowthEPS=+55.4% | GrowthRev=+6.3%
EPS next Year (2027-12-31): EPS=3.89 | Chg30d=-4.20% | Revisions=-70% | GrowthEPS=+30.4% | GrowthRev=+8.4%
[Analyst] Revisions Ratio: -72% (up=2, down=20)